BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
59.78
-1.59 (-2.59%)
May 13, 2025, 4:00 PM - Market closed

BioMarin Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
1,049942.84755.13724.53587.28649.16
Upgrade
Short-Term Investments
223.53194.86318.68567.01426.6416.23
Upgrade
Cash & Short-Term Investments
1,2721,1381,0741,2921,0141,065
Upgrade
Cash Growth
21.57%5.95%-16.86%27.39%-4.83%41.33%
Upgrade
Accounts Receivable
739.18660.54633.7461.32373.4448.35
Upgrade
Receivables
739.18660.54633.7461.32373.4448.35
Upgrade
Inventory
1,2751,2331,107894.08776.67698.55
Upgrade
Other Current Assets
181.55201.53141.39104.52110.44129.93
Upgrade
Total Current Assets
3,4683,2322,9562,7512,2742,342
Upgrade
Property, Plant & Equipment
1,0331,0771,1121,1141,0821,090
Upgrade
Long-Term Investments
506.72527.84622.44370.34524.29295.97
Upgrade
Goodwill
196.2196.2196.2196.2196.2196.2
Upgrade
Other Intangible Assets
247.35327.38325.3338.57388.65417.27
Upgrade
Long-Term Deferred Tax Assets
1,4611,4891,5461,5051,4501,432
Upgrade
Other Long-Term Assets
235.65138.9483.5698.7889.274.63
Upgrade
Total Assets
7,1476,9896,8426,3756,0055,848
Upgrade
Accounts Payable
293.75235.4315.51231.24199.68191.43
Upgrade
Accrued Expenses
276.67331.27311.55293.53267.65257.27
Upgrade
Current Portion of Long-Term Debt
--493.88---
Upgrade
Current Portion of Leases
6.317.578.7810.3810.4611.75
Upgrade
Current Income Taxes Payable
23.9412.572.6516.211.219.66
Upgrade
Current Unearned Revenue
-1.374.620.716.960.15
Upgrade
Other Current Liabilities
27.5418.840.0436.8160.5422.29
Upgrade
Total Current Liabilities
628.21606.991,177588.88546.5492.55
Upgrade
Long-Term Debt
595.65595.14593.11,0831,0791,075
Upgrade
Long-Term Leases
-31.2638.1226.5133.8444.49
Upgrade
Other Long-Term Liabilities
129.6997.5781.8173.579.69129.84
Upgrade
Total Liabilities
1,3541,3311,8901,7721,7391,742
Upgrade
Common Stock
0.190.190.190.190.180.18
Upgrade
Additional Paid-In Capital
5,7945,8025,6125,4055,1924,993
Upgrade
Retained Earnings
-9.01-194.7-621.55-789.2-930.76-861.61
Upgrade
Comprehensive Income & Other
7.9750.43-38.65-12.734.74-25.98
Upgrade
Shareholders' Equity
5,7935,6584,9524,6034,2664,106
Upgrade
Total Liabilities & Equity
7,1476,9896,8426,3756,0055,848
Upgrade
Total Debt
601.96633.971,1341,1201,1231,131
Upgrade
Net Cash (Debt)
670.38503.74-60.07171.63-109.51-66
Upgrade
Net Cash Per Share
3.422.56-0.310.91-0.60-0.34
Upgrade
Filing Date Shares Outstanding
191.78190.78188.68186.53184.03181.83
Upgrade
Total Common Shares Outstanding
191.76190.76188.6186.25183.91181.74
Upgrade
Working Capital
2,8402,6251,7792,1631,7281,850
Upgrade
Book Value Per Share
30.2129.6626.2524.7123.1922.59
Upgrade
Tangible Book Value
5,3505,1344,4304,0683,6813,493
Upgrade
Tangible Book Value Per Share
27.9026.9223.4921.8420.0119.22
Upgrade
Land
-90.7890.7890.7990.4290.42
Upgrade
Buildings
-892.48860.81819.1774.92761.56
Upgrade
Machinery
-789.5796.61736.25688.54644.4
Upgrade
Construction In Progress
-90.27100.01143.38136.74109.14
Upgrade
Leasehold Improvements
-44.3758.2359.5355.2855.13
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q